Stock Groups

Citrix Systems Earnings Beat, Revenue Misses In Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Citrix Systems Earnings Beat, Revenue Misses In Q3

Citrix System (NASDAQ:), a website owned by Investing.com, reported Thursday its third quarter results. They beat analyst forecasts while revenue fell below expectations.

Citrix Systems reported earnings per share at $1.2 on revenues of $778.5M. Investing.com polled analysts and predicted EPS at $0.8905 for revenue $782.31M.

Citrix Systems shares have fallen 27% since the start of the year. However, they are still 35.02% below their 52-week high of $144.96 on January 27. The Nasdaq is performing better than them, which has risen 22.68% since the beginning of the year.

Citrix Systems reports on other top-tier earnings from the Technology sector in this month’s Citrix Systems

Citrix Systems reported on the earnings beat of Alphabet C (October 26), who reported an EPS figure of $27.99 on revenues of $65.12B. Forecasts for EPS were $23.83 and revenue of $63.53B.

Taiwan Semiconductor beat all expectations with a third quarter earnings per share of $1.07 on $14.75B revenue, as compared to $1.04 forecast on $14.81B revenue.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]